This company develops precision diagnostic tools that analyze whole genome sequencing data to identify resistance-prone infections and track their spread. Their platform helps hospitals and clinicians make targeted treatment decisions, improving patient outcomes and reducing the cost of resistant infections.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The increasing prevalence of antibiotic-resistant infections poses a significant global health threat, leading to higher mortality rates, prolonged hospital stays, and increased healthcare costs. Current diagnostic methods, such as bacterial culturing, are slow and often result in empirical treatment, contributing to antibiotic misuse and further resistance emergence. A lack of rapid and precise diagnostics hinders targeted treatment decisions and effective infection control measures.
Solution
Informuta leverages machine learning and whole genome sequencing (WGS) data to provide a precision diagnostic tool, RESISENSE, for identifying and predicting antibiotic resistance in infections. The platform analyzes a patient's infection at the DNA level to determine the most effective antibiotic treatments on a patient-by-patient basis. By providing comprehensive information on infections, Informuta enables clinicians to make targeted treatment decisions, improving patient outcomes and reducing the incidence and cost of resistant infections. The technology aims to predict drug resistance before it occurs, allowing for proactive intervention and improved patient management.
Target Audience
The primary target audience includes hospitals, clinicians, and researchers focused on combating antibiotic resistance and improving infectious disease management.
Features
- Utilizes whole genome sequencing (WGS) for comprehensive analysis of bacterial infections.
- Employs machine learning algorithms to predict antibiotic resistance patterns.
- Provides rapid results, significantly reducing time to diagnosis compared to traditional methods.
- Enables personalized treatment plans based on individual patient and infection characteristics.
- Offers a more precise and sensitive diagnostic approach compared to standard bacterial culturing.
- Aims to predict drug resistance before it manifests, allowing for proactive treatment strategies.